The North America mobile cardiac telemetry systems market is expected to reach US$ 606,198.8 Mn in 2027 from US$ 218,087.2 Mn in 2018. The market is estimated to grow with a CAGR of 12.6% from 2019-2027.
The growth of the market is driven by the factors such as, benefits of monitoring patients with mobile cardiac telemetry (MCT) and rising geriatric population. However, the market is likely to slower down its growth due to stringent regulations for approval in the region.
The mobile cardiac telemetry (MCT) system is a small sensor and monitor that patients wear in their day to day life. MCT promptly transmits the data on occurrence of cardiac event, to the center for analysis and responding. Post analysis a report is generated along with graphs and trends for the diagnosis and therapy management. This is a cost saving procedure in the hospital for ablation, CABG, heart/pericardium, and valve/septa procedures. The MCT offers up to 30 days of retrievable ECG data, A-Fib onset and offset, episode, daily summary, and urgent notifications, and full disclosure report on demand. It is an advanced algorithm that computes heart rate and detects asymptomatic and symptomatic arrhythmia at a wide variety of rates and durations.
MCT is highly effective method of cardiac monitoring. The ability to analyse every heartbeat with little interference to the patient’s normal day, and the opportunity to initiate an immediate emergency response as needed, makes it one of the most attractive choices in today’s market. It delivers advantages to both the patient and the physician that can lead to more efficient care.
US is expected to lead the market in the North America region owing to the rising prevalence of the cardiac conditions and increase in research and development of the medical technologies. Moreover, several companies operating in the market for the mobile cardiac telemetry in the country, which helps to upsurge the market growth. Therefore, considering the above mentioned factors the growth of the market in the country is likely to contribute largest share in the North America region during the forecast period.
Exhibit: Mexico Mobile Cardiac Telemetry Systems Market Revenue and Forecasts to 2027
(US$ Mn)
NORTH AMERICA MOBILE CARDIAC TELEMETRY SYSTEMS – MARKET SEGMENTATION
By Technology
- Lead Based
- Patch Based
By End User
- Hospitals
- Ambulatory Surgical Centres
- Cardiac Centres
By Geography
-
North America
- US
- Canada
- Mexico
Company Profiles
- Medtronic
- BioTelemetry Inc.
- Applied Cardiac Systems, Inc
- Medicomp Inc
- Preventice Services, LLC
- The Scottcare Corporation
- Medi-Lynx (Subisidiary Of Medicalgorithmics, S.A),
- Zoll Medical Corporation
- Welch Allyn
- Telerhythmics, LLC
North America Mobile Cardiac Telemetry Systems Market Strategic Insights
North America Mobile Cardiac Telemetry SystemsMarket Report Highlights
| Report Attribute | Details |
| Market size in 2018 | US$ 218,087.2 Million |
| Market Size by 2027 | US$ 606,198.8 Million |
| CAGR (2019 - 2027) | 12.6% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Technology
|
|
Regions and Countries Covered
|
|
| North America | US, Canada, Mexico |
| Market leaders and key company profiles |
|
North America Mobile Cardiac Telemetry Systems Market Country and Regional Insights
